Trial Profile
Comparison across Etanercept, Adalimumab, Golimumab and Infliximab in patient with Psoriatic Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2018
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Golimumab (Primary) ; Infliximab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- 18 Jul 2018 New trial record
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism